	Bayesian reanalysis of the NIAGARA trial using reconstructed individual patient data: perioperative durvalumab in cisplatin-eligible muscle-invasive bladder cancer. Jpn J Clin Oncol Hirose K, Yoshida S, Chen W, Yajima S, Sato H, Hirakawa A, Tanabe K, Fujiwara M, Fukushima H, Yasuda Y, Tanaka H, Masuda H, Fujii Y. PMID: 42053502 [PubMed - as supplied by publisher]
	A Gene Expression Tumor Signature Optimizing Partial Area-Under-the-Curve (pAUC) to Improve Specificity for Indolent Prostate Cancer. Prostate Gerke TA, Tyekucheva S, Stopsack KH, Sweeney CJ, Lis RT, Westling EN, Loda M, Stampfer MJ, Penney KL, Parmigiani G, Mucci LA. PMID: 42053424 [PubMed - as supplied by publisher]
	Laparoscopic radical cystectomy in patients with bladder cancer: A modified technique with reduced morbidity - A comparative study. Urologia Sharma A, Biswal D, Sharma S, Ravani Thrilochana R, Yadav P, Goel S, Alam P. PMID: 42053413 [PubMed - as supplied by publisher]
	Myosteatosis Predicts Poor Prognosis in Patients With Castration-Resistant Prostate Cancer Treated With Enzalutamide. Int J Urol Kanaki T, Hatano K, Oka T, Tani M, Konishi M, Liu Y, Horitani H, Matsukawa A, Inoguchi S, Yoshimura A, Horibe Y, Sassi N, Okuda Y, Ishizuya Y, Hayashi T, Yamamoto Y, Kato T, Kawashima A, Nonomura N. PMID: 42053360 [PubMed - indexed for MEDLINE]
	Incidence of thromboembolic events in testicular cancer patients receiving cisplatin (TESTCIS study). J Oncol Pharm Pract Dubois M, Joly M, Dionne A, Audet N, Dancause MH. PMID: 42053273 [PubMed - as supplied by publisher]
	Surgical management of metastatic squamous cell carcinoma of the bladder: a case report and review of the literature. Front Oncol Schwartz M, Hartman C, McClintock G, Caulfield S, Jagirdar J, Harik L, Berkowitz D, Fernandez F, Oza S, Narayan V, Brown JT. PMID: 42052454 [PubMed]
	Multilayered analysis of cisplatin resistance mechanisms in bladder cancer: from the cell membrane to organelles. PeerJ Ma L, Tao Y, Cheng L, You C, Xiao X, Yang W, Liu Y, Dong Z. PMID: 42052167 [PubMed - indexed for MEDLINE]
	Detection rate of [(99m)Tc]Tc-PSMA SPECT/CT in prostate cancer: a systematic review and a meta-analysis. Front Med (Lausanne) Albano D, Tasevski S, Sadeghi R, Treglia G, Rizzo A. PMID: 42051703 [PubMed]
	A multidimensional nomogram integrating immune, inflammatory, and coagulation markers for personalized prognosis in bladder cancer. J Int Med Res Li Y, Wei W, Liu C, Lu H, Chen R, Wu S, Lin Y, Xie H, Ban C, Yi X, Tang Y. PMID: 42050916 [PubMed - indexed for MEDLINE]
	Indirect Comparison of Neoadjuvant Treatment Strategies for Muscle-Invasive Bladder Cancer: ddMVAC and Perioperative Durvalumab-Gemcitabine-Cisplatin Versus Gemcitabine-Cisplatin: A Systematic Review and Network Meta-Analysis of Randomised Controlled Trials. Int J Cancer Mangold MH, Baumann G, Wieland VLS, Carl N, Renner LV, Studier-Fischer A, Menold H, Zschäbitz S, Wessels F, Westhoff N, Michel MS, Kowalewski KF, Haney-Aubert CM. PMID: 42050770 [PubMed - as supplied by publisher]
	Neoadjuvant hormone therapy plus robot-assisted radical prostatectomy improves pathologic outcomes in high-risk prostate cancer: a retrospective cohort study. BMC Urol Fan J, Liu S, Li Z, Xv Y, Li T, Huang S, Feng C, Liu J, Li D, Jiang F. PMID: 42050599 [PubMed - as supplied by publisher]
	Long-term risk of depression in lung, colon, breast, and prostate cancer: a 25-year nationwide comparative study. BMC Cancer Borg M, Farver-Vestergaard I, Hilberg O, Steed L, Nissen L, Ibsen R, Løkke A. PMID: 42050470 [PubMed - as supplied by publisher]
	Correction: Clinically significant prostate cancer detection with deep learning in a multi-center magnetic resonance imaging study. Sci Rep Alzate-Grisales JA, Mora-Rubio A, Perán-Teruel M, Beltrán AN, Torres CR, García JMO, García-García F, Tabares-Soto R, García-Gómez JM, de la Iglesia-Vayá M. PMID: 42050081 [PubMed - in process]
	Evaluating Clinically Significant Prostate Cancer with Pathology-Registered Radiomics: A Multi-Reader Assessment Using Lesion Diameter-based Simplified Segmentations on MRI. Acad Radiol Esengur OT, Harmon SA, Gelikman DG, Yilmaz EC, Zhang H, Simon B, An JY, Azamat S, Law YM, Margolis DJA, Marko J, Panebianco V, Merino MJ, Gurram S, Wood BJ, Lis R, Choyke PL, Pinto PA, Turkbey B. PMID: 42049617 [PubMed - as supplied by publisher]
	European Association of Urology Guidelines on Testicular Cancer: Summary of the 2026 Guidelines. Eur Urol Patrikidou A, Cazzaniga W, Oing C, Berney D, Lobo J, Boormans J, Fankhauser C, Fischer S, Leao R, Gravina C, Nardo DD, Cornes R, Janisch F, Bezuidenhout C, Haugnes HS, Papachristofilou A, Tandstad T, Heidenreich A. PMID: 42049597 [PubMed - as supplied by publisher]
	Metastasis-directed Therapy With or Without Pembrolizumab for Oligometastatic Clear Cell Renal Cell Carcinoma: Pooled Analysis of Two Prospective Single-arm Phase 2 Trials. Eur Urol Sherry AD, To V, D'souza C, Kiany S, Thio N, Liu S, Sun X, Castle B, Macdonald S, Choi H, Seo A, Hara K, Pryor D, Azad A, Tran B, Au L, Spain L, Ludmir EB, Jonasch E, Tannir NM, Msaouel P, Neeson P, Haymaker C, Tang C, Siva S. PMID: 42049596 [PubMed - as supplied by publisher]
	European Association of Urology and American Society of Clinical Oncology Guidelines on Penile Cancer: A Summary of the 2026 Guidelines Update. Eur Urol Parnham A, Albersen M, Ayres B, Crook J, Johnstone PAS, Oliveira P, Pagliaro LC, Pettaway C, Protzel C, Bryan Rumble R, Sánchez Martínez DF, Spiess PE, van der Heijden MS, Barreto L, Garcia-Perdomo HA, Greco I, Patterson K, Manzie K, Marcus JD, Osborne J, Bezuidenhout C, Tagawa S, Brouwer O. PMID: 42049595 [PubMed - as supplied by publisher]
	Reply to Ashwini Kadam, Ankit Misra and Gagan Prakash's Letter to the Editor Re: Chase Peng Yun Ng, Alexander Light, Sai Kalpitha Eragamreddy, et al. Five-year Outcomes for Men after Negative Magnetic Resonance Imaging (MRI) or Negative Biopsy in the RAPID MRI-directed Prostate Cancer Diagnostic Pathway. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2025.10.015. Eur Urol Ng CPY, Light A, Ahmed H, Shah T. PMID: 42049594 [PubMed - as supplied by publisher]
	Digital PCR-Based Uromonitor for Molecular Detection of Bladder Cancer: A Multicenter Validation Study Comparing Quantitative PCR and Urine Cytology. Clin Genitourin Cancer Kravchuk A, Garzaro JRR, Wirtz R, Wolff I, Koch S, Schlomm T, Rabien A, Meisl C, Rong D, Brás JP, Vinagre J, Otto T, Barski D, Gössl A, Siepmann S, Gilfrich C, Brookman-May S, Ecke T, May M. PMID: 42049549 [PubMed - as supplied by publisher]
	Older Age and Outcomes of Intravesical Bacillus Calmette-GuÃ©rin for Non-muscle-invasive Bladder Cancer. In Vivo Furubayashi N, Tsujita J, Takayama A, Shiraishi Y, Nakamura M, Negishi T. PMID: 42049417 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 177842

Page 1 of 8893



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy